과제정보
This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2016R1A6A3A11932463).
참고문헌
- Bousfiha AA, Jeddane L, Ailal F, Benhsaien I, Mahlaoui N, Casanova JL, et al. Primary immunodeficiency diseases worldwide: more common than generally thought. J Clin Immunol 2013;33:1-7.
- The United States Immunodeficiency Network (USIDNET) [Internet]. Towson (MD): USIDNET; [cited 2019 June 27]. Available from: www.USIDNET.org.
- Registry Working Party ESID Registry [Internet]. Amsterdam (The Netherlands): European Society for Immunodeficiencies (ESID); [cited 2019 Oct 7]. Available from: https://esid.org/Working-Parties/RegistryWorking-Party/ESID-Registry.
- Ishimura M, Takada H, Doi T, Imai K, Sasahara Y, Kanegane H, et al. Nationwide survey of patients with primary immunodeficiency diseases in Japan. J Clin Immunol 2011;31:968-76. https://doi.org/10.1007/s10875-011-9594-7
- Kirkpatrick P, Riminton S. Primary immunodeficiency diseases in Australia and New Zealand. J Clin Immunol 2007;27:517-24. https://doi.org/10.1007/s10875-007-9105-z
- Modell V, Knaus M, Modell F, Roifman C, Orange J, Notarangelo LD. Global overview of primary immunodeficiencies: a report from Jeffrey Modell Centers worldwide focused on diagnosis, treatment, and discovery. Immunol Res 2014;60:132-44. https://doi.org/10.1007/s12026-014-8498-z
- Espinosa-Rosales FJ, Condino-Neto A, Franco JL, Sorensen RU. Into action: improving access to optimum care for all primary immunodeficiency patients. J Clin Immunol 2016;36:415-7. https://doi.org/10.1007/s10875-016-0277-2
- Modell V, Orange JS, Quinn J, Modell F. Global report on primary immunodeficiencies: 2018 update from the Jeffrey Modell Centers Network on disease classification, regional trends, treatment modalities, and physician-reported outcomes. Immunol Res 2018;66:367-80. https://doi.org/10.1007/s12026-018-8996-5
- World Population Prospects: United Nations Department of Economic and Social Affairs (UN DESA). New York: United Nations; [cited 2017 June 21]. Available from: https://www.un.org/development/desa/publications/world-population-prospects-the-2017-revision.html.
- Rhim JW, Kim KH, Kim DS, Kim BS, Kim JS, Kim CH, et al. Prevalence of primary immunodeficiency in Korea. J Korean Med Sci 2012;27:788-93. https://doi.org/10.3346/jkms.2012.27.7.788
- Bousfiha A, Jeddane L, Picard C, Ailal F, Bobby Gaspar H, Al-Herz W, et al. The 2017 IUIS phenotypic classification for primary immunodeficiencies. J Clin Immunol 2018;38:129-43. https://doi.org/10.1007/s10875-017-0465-8
- Casanova JL, Conley ME, Seligman SJ, Abel L, Notarangelo LD. Guidelines for genetic studies in single patients: lessons from primary immunodeficiencies. J Exp Med 2014;211:2137-49. https://doi.org/10.1084/jem.20140520
- Meyts I, Bosch B, Bolze A, Boisson B, Itan Y, Belkadi A, et al. Exome and genome sequencing for inborn errors of immunity. J Allergy Clin Immunol 2016;138:957-69. https://doi.org/10.1016/j.jaci.2016.08.003
- Al-Mousa H, Abouelhoda M, Monies DM, Al-Tassan N, Al-Ghonaium A, Al-Saud B, et al. Unbiased targeted next-generation sequencing molecular approach for primary immunodeficiency diseases. J Allergy Clin Immunol 2016;137:1780-7. https://doi.org/10.1016/j.jaci.2015.12.1310
- Mamcarz E, Zhou S, Lockey T, Abdelsamed H, Cross SJ, Kang G, et al. Lentiviral gene therapy combined with low-dose busulfan in infants with SCID-X1. N Engl J Med 2019;380:1525-34. https://doi.org/10.1056/NEJMoa1815408
- Fischer A, Hacein-Bey Abina S, Touzot F, Cavazzana M. Gene therapy for primary immunodeficiencies. Clin Genet 2015;88:507-15. https://doi.org/10.1111/cge.12576
- Press release: the nobel prize in physiology or medicine 2018, a new principle for immune therapy: The Nobel Foundation [Internet]. Stockholm (Sweden): The Nobel Foundation; c2020 [cited 2018 Oct 1]. Available from: https://www.nobelprize.org/prizes/medicine/2018/pressrelease/.
- Lee S, Moon JS, Lee CR, Kim HE, Baek SM, Hwang S, et al. Abatacept alleviates severe autoimmune symptoms in a patient carrying a de novo variant in CTLA-4. J Allergy Clin Immunol 2016;137:327-30. https://doi.org/10.1016/j.jaci.2015.08.036
- Lo B, Zhang K, Lu W, Zheng L, Zhang Q, Kanellopoulou C, et al. Autoimmune disease. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy. Science 2015;349:436-40. https://doi.org/10.1126/science.aaa1663
- Egg D, Schwab C, Gabrysch A, Arkwright PD, Cheesman E, Giulino-Roth L, et al. Increased risk for malignancies in 131 affected CTLA4 mutation carriers. Front Immunol 2018;9:2012. https://doi.org/10.3389/fimmu.2018.02012
- Impact of NIH Research: National Institutes of Health (NIH) [Internet]. Bethesda (MD): National Institutes of Health; [cited 2018 May 1]. Available from: https://www.nih.gov/about-nih/what-we-do/impact-nihresearch/our-society.
- Primary immunodeficiencies (2016-2017) [Internet]. Grantome: c2015; [cited 12019 Oct 10]. Available from: http://grantome.com/search?q=primary+immunodeficiencies.
- USIDNET (2016-2017) [Internet]. Grantome: c2015; [cited 2018 Month Day]. Available from: http://grantome.com/search?q=USIDNET.
- About USIDNET: US Immunodeficiency Network (USIDNET) [Internet]. Towson (MD): USIDNET; [cited 2019 Oct 6]. Available from: https://usidnet.org/.
- Survey of patients with primary immunodeficiency in Korea [Internet]. Cheongju (Korea): Korea Centers for Disease Control and Prevention (KCDC); [cited 2007 Sep 5]. Available from: http://www.cdc.go.kr/CDC/notice/CdcKrInfo0201.jsp?menuIds=HOME001-MNU1154-MNU0005-&fid=28&q_type=title&q_value=%EB%A9%B4%EC%97%AD%EA%B2%B0%ED%95%8D&cid=1188&pageNum=1.
- Yi ES, Choi YB, Lee NH, Lee JW, Sung KW, Koo HH, et al. Allogeneic hematopoietic cell transplantation in patients with primary immunodeficiencies in Korea: eleven-year experience in a single center. J Clin Immunol 2018;38:757-66. https://doi.org/10.1007/s10875-018-0542-7
- Lee JH, Sohn WY, Park HY, Hwang SJ, Seo WH, Kim SJ, et al. A clinical study of primary immunodeficiency disease in a single center in seoul from 1996 to 2004. Pediatr Allergy Respir Dis 2005;15:368-80.
- Ju HY, Kang HJ, Hong CR, Lee JW, Kim H, Song SH, et al. Targeted busulfan and fludarabine-based conditioning for bone marrow transplantation in chronic granulomatous disease. Korean J Pediatr 2016;59:S57-9. https://doi.org/10.3345/kjp.2016.59.11.S57
- Kim JS, Hwang J, Choi YH, Kim WS, Kim JG. A case of esophageal obstruction complicated in a patient with chronic granulomatous disease: esophageal obstruction in chronic granulomatous disease. Korean J Pediatr Infec Dis 2014;21:53-8. https://doi.org/10.14776/kjpid.2014.21.1.53
- Kim L, Kim JA, Kim S. A guide for the utilization of Health Insurance Review and Assessment Service National Patient Samples. Epidemiol Health 2014;36:e2014008.
- The Sixth Revision of the Korean Standard Classification of Diseases: Statistics Korea [Internet]. Daejeon (Korea): Statistics Korea; [cited 2010 Jul 13]. Available from: http://kostat.go.kr/portal/eng/news/3/index.board?bmode=read&aSeq=71706.
- Classification of Disease (ICD) [Internet]. Geneva (Switzerland): World Health Organization; [cited 2019 Oct 10]. Available from: https://www.who.int/classifications/icd/icdonlineversions/en/.
피인용 문헌
- Needs for Increased Awareness of Gastrointestinal Manifestations in Patients With Human Inborn Errors of Immunity vol.12, 2021, https://doi.org/10.3389/fimmu.2021.698721